MannKind Q3 2024 Earnings Call Transcript
MNKD Stock | USD 6.78 0.17 2.57% |
About 69 percent of all MannKind Corp's shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding MannKind Corp suggests that quite a large number of traders are confidant. The current market sentiment, together with MannKind Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use MannKind Corp stock news signals to limit their universe of possible portfolio assets.
MannKind |
MNKD earnings call for the period ending September 30, 2024.
Read at fool.com
MannKind Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards MannKind Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MannKind Corp Fundamental Analysis
We analyze MannKind Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MannKind Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MannKind Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
MannKind Corp is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
MannKind Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MannKind Corp stock to make a market-neutral strategy. Peer analysis of MannKind Corp could also be used in its relative valuation, which is a method of valuing MannKind Corp by comparing valuation metrics with similar companies.
Peers
MannKind Corp Related Equities
VSTM | Verastem | 16.85 | ||||
KTTA | Pasithea Therapeutics | 6.55 | ||||
ELEV | Elevation Oncology | 3.23 | ||||
IMMP | Immutep | 2.01 | ||||
DAWN | Day One | 1.53 | ||||
INKT | Mink Therapeutics | 1.39 | ||||
BMRN | Biomarin Pharmaceutical | 0.93 | ||||
PCVX | Vaxcyte | 0.38 | ||||
TECH | Bio Techne | 0.03 | ||||
LQDA | Liquidia Technologies | 0.60 | ||||
SABS | SAB Biotherapeutics | 1.02 | ||||
AFMD | Affimed NV | 1.05 | ||||
KNSA | Kiniksa Pharmaceuticals | 1.08 | ||||
ADAP | Adaptimmune Therapeutics | 1.37 | ||||
SGMO | Sangamo Therapeutics | 1.74 | ||||
UTHR | United Therapeutics | 2.02 | ||||
LEGN | Legend Biotech | 2.46 | ||||
LRMR | Larimar Therapeutics | 4.67 |
Complementary Tools for MannKind Stock analysis
When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
CEOs Directory Screen CEOs from public companies around the world |